ReviewFrontiers in endocrinology2022

Neoadjuvant B-RAF and MEK Inhibitor Targeted Therapy for Adult Papillary Craniopharyngiomas: A New Treatment Paradigm.

Francesco Calvanese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.